Literature DB >> 33664423

Association of fall risk factors and non-motor symptoms in patients with early Parkinson's disease.

Kyum-Yil Kwon1, Suyeon Park2, Eun Ji Lee3, Mina Lee3, Hyunjin Ju3.   

Abstract

The association of non-motor symptoms (NMSs) with fall-related factors in patients with Parkinson's disease (PD) remains to be further elucidated in the early stages of the disease. Eighty-six patients with less than 5 years of the onset of PD were retrospectively enrolled in the study. We assessed potential fall-related risk factors including (1) a history of falls during the past year (faller versus non-faller), (2) the fear of falling (FoF), and (3) the freezing of gait (FoG). Different types of NMSs were measured using the Montreal Cognitive Assessment (MoCA), the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI), the Parkinson's disease Fatigue Scale (PFS), and the Scales for Outcomes in Parkinson's disease-Autonomic dysfunction (SCOPA-AUT). The faller group (37.2%) showed higher scores for BDI, BAI, PFS, and SCOPA-AUT, compared to the non-faller group. From logistic regression analyses, the prior history of falls was related to the gastrointestinal domain of SCOPA-AUT, FoF was associated with BAI, and gastrointestinal and urinary domains of SCOPA-AUT, and FoG was linked to BAI and gastrointestinal domain of SCOPA-AUT. In conclusion, we found that fall-related risk factors in patients with early PD were highly connected with gastrointestinal dysautonomia.

Entities:  

Mesh:

Year:  2021        PMID: 33664423      PMCID: PMC7933250          DOI: 10.1038/s41598-021-84720-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  30 in total

1.  The Parkinson fatigue scale.

Authors:  R G Brown; A Dittner; L Findley; S C Wessely
Journal:  Parkinsonism Relat Disord       Date:  2005-01       Impact factor: 4.891

Review 2.  Clinical measures of progression in Parkinson's disease.

Authors:  Werner Poewe
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

Review 3.  Gait impairments in Parkinson's disease.

Authors:  Anat Mirelman; Paolo Bonato; Richard Camicioli; Terry D Ellis; Nir Giladi; Jamie L Hamilton; Chris J Hass; Jeffrey M Hausdorff; Elisa Pelosin; Quincy J Almeida
Journal:  Lancet Neurol       Date:  2019-04-08       Impact factor: 44.182

4.  The association between freezing of gait, fear of falling and anxiety in Parkinson's disease: a longitudinal analysis.

Authors:  Ires Ghielen; Perrie Koene; Jos Wr Twisk; Gert Kwakkel; Odile A van den Heuvel; Erwin Eh van Wegen
Journal:  Neurodegener Dis Manag       Date:  2020-06-17

5.  The functional network signature of heterogeneity in freezing of gait.

Authors:  Kaylena A Ehgoetz Martens; Julie M Hall; Matthew J Georgiades; Moran Gilat; Courtney C Walton; Elie Matar; Simon J G Lewis; James M Shine
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

6.  Fall frequency and risk assessment in early Parkinson's disease.

Authors:  T S Voss; J J Elm; C L Wielinski; M J Aminoff; D Bandyopadhyay; K L Chou; L R Sudarsky; B C Tilley
Journal:  Parkinsonism Relat Disord       Date:  2012-04-26       Impact factor: 4.891

Review 7.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

Review 8.  Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  David J Thurman; Judy A Stevens; Jaya K Rao
Journal:  Neurology       Date:  2008-02-05       Impact factor: 9.910

9.  Recurrent falls in Parkinson's disease: a systematic review.

Authors:  Natalie E Allen; Allison K Schwarzel; Colleen G Canning
Journal:  Parkinsons Dis       Date:  2013-03-05

Review 10.  Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies.

Authors:  M-C Wen; L L Chan; L C S Tan; E K Tan
Journal:  Eur J Neurol       Date:  2016-06       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.